Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells

Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells

Cleveland Clinic

1 month
13 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Kailin Yang, MD of Cleveland Clinic discusses targeting metabolic reprogramming to radiosensitize glioblastoma stem cells.

_________

Inhibiting two critical steps in the metabolism of glioblastoma stem cells (GSCs) attenuates GSC self-renewal and reduces tumorigenesis, finds a new study presented at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

“Determining how to target glioma stem cells effectively has been a major challenge in treating glioblastoma [GBM],” says Kailin Yang, MD, PhD, a radiation oncology resident at Cleveland Clinic Cancer Center who presented the abstract under the supervision of Jeremy Rich, MD, MHS, of the University of California at San Diego. “Our previous studies suggested that pyrimidine synthesis is associated with clinical outcome in glioblastoma patients, and thus is a productive place to focus our energy.”

The current study demonstrates that simultaneous targeting of two vital enzymes in the pyrimidine synthetic pathway inhibits self-renewal and tumorigenesis of GSCs.

The first enzyme is rate-limiting carbamoyl-phosphate synthetase 2, aspartate transcarbamyolase, dihydroorotase (CAD). EGFR or PTEN driver mutations demonstrated distinct CAD phosphorylation patterns. The second, dihydroorotate dehydrogenase (DHODH), catalyzes the subsequent step in pyrimidine synthesis after CAD. Targeting both enzymes with clinically approved inhibitors produced sustained inhibition of the survival, self-renewal and in vivo tumor initiation of GSCs in patient-derived xenografts, when compared with single treatments.

Read the rest here: https://consultqd.clevelandclinic.org/metabolic-reprogramming-a-promising-approach-to-tackling-therapeutic-resistance-in-glioblastoma/ 

Up Next Autoplay
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
8 Views
Cleveland Clinic 1 month
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
2 Views
Cleveland Clinic 1 month
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
10 Views
Cleveland Clinic 1 month
How does this affect clinicians today?
How does this affect clinicians today?
Category: Brain Cancer
5 Views
Cleveland Clinic 1 month
Nomograms on salvage radiotherapy
Nomograms on salvage radiotherapy
Category: Pancreatic Cancer
2 Views
Cleveland Clinic 1 month
How does it differ from previously published nomograms?
How does it differ from previously published nomograms?
Category: Pancreatic Cancer
1 Views
Cleveland Clinic 1 month
Impact of Post-Prostatectomy Prostate Specific Antigen (PSA) Kinetics on Outcomes of Salvage Radiotherapy
Impact of Post-Prostatectomy Prostate Specific Antigen (PSA) Kinetics on Outcomes of Salvage Radiotherapy
Category: Prostate Cancer
1,599 Views
Cleveland Clinic 1 month
How this will affect clinicians today
How this will affect clinicians today
Category: Other
3 Views
Cleveland Clinic 1 month
Why Dose Escalation?
Why Dose Escalation?
Category: Other
4 Views
Cleveland Clinic 1 month